Search Within

Epidemiology and Biostatistics

Formats
  1. Journal Article (6567)
  2. Meeting Abstract (3333)
  3. Editorial (126)
  4. Review (100)
  5. Research Letter (87)
  6. Correspondence (82)
  7. Miscellaneous (60)
  8. Conference Paper (56)
  9. Book Section (45)
  10. Guidelines (14)
  11. Book Whole (5)
Groups
  1. Biostatistics Service (6713)
  2. Department of Medicine (5061)
  3. Population Sciences Research Program (5003)
  4. Surgery (3763)
  5. Survivorship Research (3696)
  6. Solid Tumor Oncology Division (3386)

More Groups

People
  1. Mithat Gonen (1041)
  2. Andrew Vickers (898)
  3. Sean Devlin (618)
  4. Katherine Panageas (525)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (502)

More People

Years
  1. 2025 (419)
  2. 2024 (675)
  3. 2023 (692)
  4. 2022 (735)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1403)
  2. Blood (578)
  3. Annals of Surgical Oncology (478)
  4. Cancer Research (275)
  5. Clinical Cancer Research (261)
  6. International Journal of Radiation Oncology, Biology, Physics (259)

More Publications

Publishers
  1. American Society of Clinical Oncology (1523)
  2. Elsevier Inc. (1036)
  3. Springer (952)
  4. American Association for Cancer Research (780)
  5. Elsevier Science, Inc. (695)
  6. American Society of Hematology (650)

More Publishers

Results (10475)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline variants in patients with endometrial cancer across diverse ancestries
    Meeting Abstract

    Liu, Y. L.; Gordhandas, S.; Arora, K.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E. E.; Zhou, Q.; Iasonos, A.; Selenica, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival
    Meeting Abstract

    Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Dooley, K.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in the phase 3 Alliance A031201 trial of metastatic castration resistant prostate cancer (mCRPC) treated with androgen receptor (AR)-targeted therapies
    Meeting Abstract

    Jensen, J. L.; Bobek, O.; Chan, I. C. C.; Hillman, D. W.; Heller, G.; Druley, T. E.; Morris, M. J.; Milowsky, M. I.; Beltran, H.; Bolton, K. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The performance of prostate specific antigen (PSA) testing in the population based NPCC cohort
    Meeting Abstract

    Oldenburg, J.; Bjerner, J. L.; Pasovic, L.; Mùˆller, S.; Fossa, S. D.; Carlsson, S. V.; Albertsen, P. C.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Fitzgerald, K. N.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y. B.; Zucker, M.; Lefkowitz, R. A.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer
    Meeting Abstract

    Tuli, R.; Keane, F.; Schoenfeld, J. D.; O'Connor, C.; White, C.; Chou, J. F.; Schwartz, C.; Larsen, M.; Brenner, R.; Park, W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Solit, D. B.; Walch, H. S.; Chatila, W. K.; Maron, S. B.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Schultz, N.; Berger, M. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save